Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Autism
2		Additional conditions recognized in this trial
			Attention Deficit Disorder with Hyperactivity
			Autistic Disorder
			Disease
			Hyperkinesis
3		More general conditions related to this trial
			Attention Deficit and Disruptive Behavior Disorders
			Child Development Disorders, Pervasive
			Dyskinesias
			Mental Disorders
			Mental Disorders Diagnosed in Childhood
			Nervous System Diseases
			Neurologic Manifestations
			Pathologic Processes
			Signs and Symptoms
4		Interventions listed in this trial
			Methylphenidate-extended release
			Methylphenidate-instant release
			Placebo
5		Additional drug interventions recognized in this trial
			Methylphenidate
6		More general drug interventions related to this trial
			Central Nervous System Agents
			Central Nervous System Stimulants
			Dopamine Agents
			Dopamine Uptake Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Neurotransmitter Agents
			Neurotransmitter Uptake Inhibitors
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
7		Sponsors listed in this trial
			National Institute of Mental Health (NIMH)